One Science Nutrition: Building a science-led approach to sports nutrition

One Science Nutrition was co-founded by Aman and Aniket Vachher to create credible sports nutrition products. The brand aims to cater to evolving consumer expectations around product quality and transparency. Their product range includes various supplements that support diverse fitness goals and health benefits. Future strategies involve leveraging artificial intelligence to enhance consumer experiences and product discovery. The founders emphasize maintaining core values while pursuing growth in the nutrition industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/90xr2IG
via IFTTT

Read More

Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial

Johnson & Johnson reported results from an early-stage trial of their prostate cancer drug JNJ-6143. The trial involved patients with advanced prostate cancer who had undergone multiple treatments. Results showed 77% of patients experienced a significant drop in PSA levels after treatment. Additionally, 69% of patients demonstrated confirmed partial or complete tumor response through imaging. Common side effects included nausea and elevated cholesterol levels, with one patient discontinuing treatment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GY9MseC
via IFTTT

Read More

States urged to enforce ban on reuse of single-use medical devices

The Directorate General of Health Services has issued a directive to prohibit the reuse of single-use medical devices. Violations by some private hospitals have raised concerns regarding patient safety and regulatory compliance. The directive specifically targets misuse in high-stakes medical fields such as cardiology and neurosurgery. Monitoring and enforcement of compliance by healthcare establishments have been mandated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dTYQWjS
via IFTTT

Read More

Jubilant Pharmova eyes $150 million through rupee debt sale, bankers say

Jubilant Pharmova plans to raise around Rs 14 billion ($150 million) through a three-year rupee bond offering to fund capital expenditure and refinance project-related liabilities at overseas subsidiaries. The proposed issuance, rated AA+ by India Ratings, could take place before the end of next month, according to two merchant bankers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5Ax9oDs
via IFTTT

Read More

From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plans

Biodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture will notably elevate its production capacities and diversify its contract development and manufacturing services. Biodeal is committed to fortifying existing partnerships with clients leveraging its innovative nasal and oral drug formulations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3u5xN89
via IFTTT

Read More

Cipla subsidiary clears USFDA inspection with zero observations

Cipla on Friday said a routine US Food and Drug Administration (USFDA) inspection at its wholly owned subsidiary InvaGen Pharmaceuticals' manufacturing facility in Hauppauge, Long Island, New York.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BoM65tl
via IFTTT

Read More

At 22, he built a gym machine in his garage. Now, the man behind the ‘Ferrari of fitness’ is looking to India

Technogym founder Nerio Alessandri is looking to expand the Italian fitness and wellness company's presence in India, where fitness facility membership remains below 1% of the population. Founded in 1983, Technogym has grown from a garage startup into a global brand serving athletes, gyms, luxury hotels and households.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VH8bJRr
via IFTTT

Read More